Sujit Biswas, PhD (he/him/his)

Clinical Pharmacologist
Pfizer Inc.

Poster(s):

• (M-054) Population pharmacokinetics and exposure-safety analysis of SGN-STNV (PF-08046055) in patients with locally advanced and/or metastatic solid tumors: Phase-1a/b study
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT